Where ONS Voices Talk Cancer
Join oncology nurses on the Oncology Nursing Society’s award-winning podcast as they sit down to discuss the topics important to nursing practice and treating patients with cancer.
ISSN 2998-2308
php/*
Where ONS Voices Talk Cancer
Join oncology nurses on the Oncology Nursing Society’s award-winning podcast as they sit down to discuss the topics important to nursing practice and treating patients with cancer.
ISSN 2998-2308
Copyright: © Copyright 2017
"It's the oncology nurse who might be the only cheerleader this person has to keep them motivated moving forward. We need to make sure our patients' motivation and competence stay high so that they can stay on this journey of quitting," ONS member Maureen O'Brien, MS, RN, PMHCNS, NCTTP, a certified tobacco treatment specialist at the Memorial Sloan Kettering Cancer Center in New York, NY, told Jaime Weimer, MSN, RN, AGNCS-BC, AOCNS®, oncology clinical specialist at ONS, during a discussion about the benefits of smoking cessation for patients with cancer and how oncology nurses can encourage reduction or quit attempts and support their patients through the process. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: The learner will report an increase in knowledge related to smoking treatment of people with cancer.
Episode Notes
Oncology Nursing Podcast Episode 110: FDA Takes on Tobacco Use and Its Impact on Cancer Care
ONS Voice articles:
Clinical Journal of Oncology Nursing articles:
Oncology Nursing Forum article: Smoking Prevalence and Management Among Cancer Survivors
ONS position statements:
Cancer article: Training Oncology Care Providers in the Assessment and Treatment of Tobacco Use and Dependence
Memorial Sloan Kettering Cancer Center tobacco programs:
Agency for Healthcare Research and Quality: Treating Tobacco Use and Dependence: Public Health Service Clinical Practice Guideline
Centers for Disease Control and Prevention:
American Cancer Society: Health Benefits of Quitting Smoking Over Time
U.S. Food and Drug Administration: Health Effects of Tobacco Use
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
"For every person who dies from smoking, at least 30 people will live with a serious smoking-related illness. Smoking causes cancer; heart disease; strokes; lung diseases, including chronic obstructive pulmonary disease, which include emphysema and chronic bronchitis; and diabetes. 87% of all lung cancers are directly linked to smoking. . . . One out of every three cancer deaths are directly related to smoking." Timestamp (TS) 11:50
"When and if a patient continues to smoke with a cancer diagnosis, it's because there's a high nicotine dependence. They're smoking to manage their withdrawal symptoms. The biggest withdrawal symptoms are anxiety and depression. And one might say that just being diagnosed with a cancer diagnosis is very anxiety-provoking. . . . They get very, very anxious, and the nicotine receptors in the brain will actually tell them to have a cigarette." TS 15:58
"One of the byproducts of tobacco is carbon monoxide, and that is retained in the lungs. . . . And in eight hours, we can start to reverse that. In 24 hours, the risk of a heart attack decreases if you stop smoking. In about two weeks to three months after stopping smoking, your circulation starts to improve and your lung function increases." TS 27:43
"As an oncology nurse, I think we need to start really focusing on some of the positive reasons why patients need to stop smoking in any prognosis that they have across the board. I think people respond to positive feedback better than negative feedback. That's why the benefits of smoking cessation for patients with cancer are so important to talk about." TS 29:35
"It's the oncology nurse who might be the only cheerleader this person has to keep them motivated moving forward, and that's what we need to do. We need to make sure our patients' motivation and competence stay high so that they can continue on this journey of quitting." TS 31:50
"I love the motto, 'If you see a problem, you can solve a problem.' So, no matter what level you fall on on the clinical ladder or within your administration, you always have the opportunity to promote and create positive change and do that with the leadership support," ONS member Klara Culmone, MSN, RN, OCN®, assistant nurse manager at the Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, told Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS, during a discussion about the factors involved in creating a fair and just culture. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below. This episode is part of a series on creating a culture of safety, we'll add a link to future episodes in the episode notes after the next episode airs.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0 The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: The learner will report an increase in knowledge related to creating a just and fair culture.
Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
"A fair and just culture includes encouraging and supporting people to discuss safety-related events or information with one another. This culture really includes a transparent, nonpunitive approach to reporting and learning from adverse events or close calls and even unsafe conditions. The goal is to prevent and minimize events that may cause harm." Timestamp (TS) 02:15
"Oncology nurses are critical in the establishment of this type of culture. They are leaders and often role models within their institutions. Oncology nurses understand policies, standards of care, and up-to-date evidence-based practice. Being on the front lines, oncology nurses see how these three things can come together and directly affect our patients and also the work environment. This global understanding positions the oncology nurses to be the liaison between patients, members of the healthcare team, and leadership." TS 02:43
"In health care, we really need to look at these different safety steps we have in place to prevent patient harm. It's really important to remind oncology nurses that we report safety events so that we can prevent them from happening again." TS 12:15
"Leaders need to support a questioning attitude from oncology nurses. They should stop and resolve using thoughtful, two-way questioning. We really encourage nurses to report anything that doesn't seem right so we can work together to ensure patient safety." TS 13:19
"Oncology nurses are equipped with knowledge and skills to create this culture. They can be familiar with current practices and standards of care for oncology patients and recommend changes if applicable. Oncology nurses can also participate in quality improvement projects, peer-to-peer education or re-education, and applicable competencies on their unit. Oncology nurses can also do team daily huddles at the beginning of their shifts to review their schedules for the day and perhaps any potential complications or safety issues that they may anticipate and come up with a plan." TS 19:01
"I love the motto, 'If you see a problem, you can solve a problem.' So, no matter what level you fall on on the clinical ladder or within your administration, you always have the opportunity to promote and create positive change and do that with the leadership support." TS 21:22
"The way I approach patient education conversations is to discuss it, address it, but not to emphasize it. I really like to focus on what the drug is. I mention if it's a biosimilar, I explain it, I give resources if they want it, but I really try to focus on the things that they're going to need to know in order to help be part of their care, but have readily available information to give them if they want more," ONS affiliate member Rowena (Moe) Schwartz, PharmD, BCOP, professor of pharmacy practice at the University of Cincinnati in Ohio, told Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS during a discussion about the basics of biosimilars for nurses and patients. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: The learner will report a gain in knowledge related to biosimilars.
Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
"For generic products, it's important that they are the same as the brand-name product. The differences there tend to be only inactive ingredients. And for a biosimilar, it's very similar to that biologic, and it's supposed to have no clinically meaningful differences from the reference product." Timestamp (TS) 06:46
"There was a lot of discussion about how would we identify when a patient got a biosimilar? A naming convention was implemented in 2017 that would help address understanding what particular drug a patient got at every point in care. The naming is done so that you have the core nonproprietary name, and then there's a four letter suffix added. . . . That naming convention was for all biologics that were approved that U.S. Food and Drug Administration naming guidance was implemented. And it's so that when that biologic comes out, if a biosimilar is ever approved, you would be able to differentiate." TS 12:50
"The way I approach patient education conversations is to discuss it and address it but not to emphasize it. Because then I think it almost creates a question in the person's mind, 'Is this as good?' We saw that with generics, we see that with biosimilars, and I really think that people need to know that this is the drug that you're using. They're pretty much overwhelmed, just even about the side effects. So I really like to focus on this is what the drug is, I mention if it's a biosimilar, I explain it, I give resources if they want it, but I really try to focus on the things that they're going to need to know in order to help be part of their care but have readily available information to give them if they want more." TS 17:19
"As we get more of these products, as we use them, I think that the healthcare team is becoming more comfortable. And I think that is definitely felt by patients, caregivers, and families. As people get more comfortable with the data and the understanding of these, I think that will help patients and kind of flow over to the whole team." TS 19:06
"When I draw the interprofessional team for the management of cardio-oncology patients, I always place nurses in the center of it, besides the patient, because nurses are the eyes and ears of interprofessional care 24 hours a day," ONS member Anecita Fadol, PhD, FNP-BC, FAANP, FAAN, FHKAN, associate professor at the University of Texas MD Anderson Cancer Center in Houston, told Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS, during a conversation about getting to "the heart of the matter" of symptom management for the cardiovascular complications of cancer therapies. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below. This episode is part of a series about cancer symptom management basics. We'll add a link to future episodes in the episode notes after the next episode airs.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: The learner will report an increase in knowledge related to cardiovascular complications associated with today's cancer treatments.
Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
"The most commonly reported cardiovascular toxicities can be classified into five main categories: 1. Cancer treatment-induced hypertension; 2. Cardiomyopathy, left ventricular dysfunction, or heart failure; 3. Myocarditis; 4. Vascular toxicity; and 5. Arrhythmias and QTc prolongation. These cardiovascular toxicities can be caused by the different anti-cancer agents." Timestamp (TS) 01:46
"Cardio-oncology is more complex than the straightforward cardiology practice. Because in terms of the cardiovascular complications, these symptoms can overlap. But on the other hand, it's a very interesting area of practice because, especially as a nurse, it's like you are a detective, looking into a case and trying to find out what is the main etiology." TS 23:50
"Nurses have a critical role in identification, monitoring, and management of these treatment-related cardiovascular complications, both in the inpatient setting and the outpatient setting with our cancer survivors. So, a nurse should remember in nursing practice, before administering anticancer treatments. . . a comprehensive cardiovascular history and a full cardiovascular assessment should be performed." TS 30:27
"When I have to draw the interprofessional team for the management of cardio-oncology patients, I always place nurses in the center of it, besides the patient. Because nurses are the eyes and the ears of the interprofessional care who is seeing the patient 24 hours a day. And early recognition—nurses can do it and monitor the response and all the other symptoms." TS 36:42
"Nurses are very critical in the management of these patients. Nurses are the experts in terms of doing patient teaching because we have an intimate relationship with patients. In terms of the baseline cardiovascular disease in terms of patient teaching, it is very important for nurses to teach the patient aggressive management of the known cardiac risk factors. . . because these are the ones that could cause cardiovascular complications later on when patients are receiving anticancer treatments." TS 39:05
"Cultural competence is about being able to deliver care while respecting and valuing the differences people bring with them to the table. Did we consider their uniqueness? Have we done our best to care for them in a way that's individualized?" Erica Fischer-Cartlidge, DNP, RN, AOCNS®, EBP-CH, chief clinical officer at ONS, told Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS, during a conversation about cultural considerations that can arise in cancer care and how oncology nurses can deliver culturally competent care. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by January 20, 2025. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: The learner will report an increase in knowledge related to delivering culturally competent care.
Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
"Most specifically, cultural competence is about being able to deliver care while respecting and valuing the differences people bring with them to the table." Timestamp (TS) 02:00
"We can never be fully culturally competent because people are always evolving and changing based on new experiences in their life. We should always be questioning and asking and seeking to learn, not just going to obtain a set information of knowledge and then applying that to all the people in that group." TS 04:00
"Every situation is different, but it always starts with having an open dialogue with your patients. It's important to not make assumptions about their life or their behaviors. No one is ever expected to know everything, but taking the time to ask is the first step. I think then the next thing is to read about different groups so you're more aware of differences and know what types of questions to ask." TS 06:08
"You have a patient who wants to fast for Yom Kippur but they're on chemotherapy. Do you automatically say no? If a patient is active in their church and requesting to have a prayer group hold their weekly meeting in his room while he's admitted but the visitor policy is only two people at a time, do you say no? The answer to these situations isn't always that we say yes and the rule changes, but it's more about reflecting on if we actively tried to meet their needs the best way we can. Did we consider their uniqueness? Have we done our best to care for them in a way that's individualized?" TS 10:37
"It's incumbent on us as nurses to stay informed about these newly approved drugs or new indications in drugs because we're the front line in helping these patients manage adverse events," Teresa Knoop, MSN, RN, AOCN®, nurse consultant in Nashville, TN, told Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS, during a conversation about the latest updates and approvals in oncology pharmacology. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: Participants will report an increase in knowledge related to the latest updates and approvals in oncology pharmacology.
Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
"Full approval through the Center for Drug Evaluation and Research (CDER) and FDA means that those drugs have gone through the laboratory testing, human clinical trial testing, and very extensive clinical trials to make sure that they are effective and that the benefits of those drugs outweigh the risks." TS 02:28
"In 1992, CDER established a new program that would help these drugs get expedited, particularly in life-threatening or serious diseases like cancer. So they established an accelerated approval pathway for these promising therapies. They were hoping to shorten that period of time, and a number of our cancer-fighting drugs have come onto the market through this accelerated approval pathway." TS 04:29
"When a drug gets an FDA approval, whether it be accelerated or final, then typically they get approved for one, possibly two indications on that first approval. But there are clinical trials ongoing in other diseases and in other indications. So we will then see drugs—after those clinical trials are conducted—taken to CDER for approval for that new indication." TS 24:02
"The exciting thing for our patients is that new indications often treat more advanced cancers in which you discover a biomarker and could give patients potential treatment options when other options may have been exhausted." TS 27:43
"It's incumbent on us as nurses to stay informed about these newly approved drugs or new indications in drugs because we're the front line in helping these patients manage adverse events. Many of these drugs are designed so patients have to stay on them for extended periods of time, or at least they get the greatest benefit by staying on it for extended periods of time. Our patient education is key in helping patients do that." TS 34:50
"In 2023, I think we will continue to see many new drugs that are approved. We will see new indications. I think particularly we will continue to see cellular therapy agents developed—we'll see them gain new indications. I would be willing to forecast that we're going to see more and more of specific immunomodulatory drugs or those antibody drug conjugates—all of those drugs that are designed to treat the cancer in a couple of different ways." TS 37:29
"It's important for all nurses to advocate—for themselves, for their practice, for their profession, for their patients. Without the nursing community advocating for itself, no other entity will. It is the nurses' responsibility to be their own advocate," Alec Stone, MA, MPA, ONS director of government affairs, told Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS, during a conversation about how you can advocate for oncology nursing with ONS. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: Participants will report an increase in knowledge related to advocating for oncology nursing with ONS.
Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
"ONS is the nursing voice in the cancer community, we are the cancer voice in the nursing community, and we are a member in the general health advocacy community. So we have distinct roles to play in those three buckets." Timestamp (TS) 05:47
"We'll review our priorities, we'll look at the Congressional landscape, we will assess the appetite for what's on our agenda, and then we'll prioritize legislation that we hope will eventually pass or that we think has a shot as it moves through this process." TS 14:10
"We use our members' expertise to educate elected officials; congressional staff; and federal agencies like the National Institutes of Health (NIH), U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Centers for Medicare and Medicaid Services (CMS) on the impact of legislative language on patients and providers. The ONS Health Policy Agenda is created from a lot of different moving parts that are important to oncology nurses." TS 15:43
"It's important for all nurses to advocate—for themselves, for their practice, for their profession, for their patients. Without the nursing community advocating for itself, no other entity will. . . . It is the nurses' responsibility to be their own advocate." TS 17:24
"You might ask, 'What does success look like?' When it comes to the White House, the FDA, CDC, congressional offices—when they reach out to ONS and they ask our leaders if we would provide insight into a policy as it's being created and formed, that means we have both a figurative and literal seat at the table. That is success." TS 25:25
"When we are able to connect with the things that give us meaning in our life, it makes us stronger, it makes us happier, it makes our life more fulfilled," Caroline Peacock, ACPE certified educator, LCSW, Episcopal priest, and director of spiritual health and community care at the Winship Cancer Institute of Emory University in Atlanta, GA, said in a conversation with Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS. Peacock discussed how oncology nurses can support patients' spirituality during cancer care. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: The learner will report an increase in knowledge related to spirituality in cancer care.
Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
"When my team and I are approaching patients, what we want to know is what matters to that particular patient, what gives them a sense of meaning, what gives them a sense of purpose in their life—and we want to approach them without judgement." Timestamp (TS) 04:22
"If you have a patient who is experiencing distress, I often recommend that you don't say, 'Would you like to see the chaplain?' or, 'Would you like to see spiritual health?' I often recommend that you make the referral. We know how to interface with a patient. The reason I recommend that is because a lot of times, there's a stigma associated with receiving help when someone is in distress." TS 13:51
"When a person has a new diagnosis, that can be so overwhelming. Often, once they have a plan in place with their provider, their distress goes way down. I do think that after that first diagnosis, that's often a point where spiritual health might want to interface, and when there's changes in goals of care." TS 16:23
"When we are able to connect with the things that give us meaning in our life, it makes us stronger, it makes us happier, it makes our life more fulfilled." TS 23:37
"Let's say a patient is just talking your ear off. . . and the nurse just doesn't have the time or capacity to tend to the patient. It might be helpful to call in spiritual health to provide a little bit of companionship to that patient. That can actually help the nurse to be more effective in their work so they're able to the medical needs that they're needing to get to while we can absorb some of the spiritual and emotional content that the patient might be carrying." TS 28:06
"A very simple question is, 'What matters to you?' It's so basic, but I think that can help a nurse get to, when they're having a conversation with a patient, what gives the patient a sense of meaning in their life. . . . And I think one thing that's really important is to know that spirituality and religion are very complex. There's a lot of diversity within any given group. It's important for nurses to know that when they're interfacing with a patient of a particular religious background not to assume that they maybe have all the same beliefs as other people within that particular religious group." TS 30:07
"We consider staff to be part of our groups of people that we're responding to, and my team and I care deeply about our nurses that work in healthcare settings. . . . Nurses have complex lives, and they're dealing with all kinds of things within their own lives—challenges with family, appointment stressors, working very hard hours, having really hard patients, having heavy caseloads—all of those things can be extraordinarily overwhelming for healthcare staff and for nurses in particular." TS 26:31
What is it like to guide a professional association that serves more than 100,000 oncology nurses? ONS Directors-at-Large Deborah "Hutch" Allen, PhD, RN, CNS, FNP-BC, AOCNP®, Kris Mathey, MS, APRN-CNP, AOCNP®, and Jeanene "Gigi" Robison, MSN, APRN, AOCN®, reflect on how their varied nursing backgrounds and ONS experiences help the ONS Board to support a diverse membership during a conversation with ONS Executive Director Lori Brown. They also shared the professional and personal rewards that nurses can reap when getting involved with ONS at any level. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: The learner will report an increase in knowledge related to oncology nursing leadership opportunities.
Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
Deborah "Hutch" Allen: "The local, national, and making international connections has provided me with a lot of opportunities for networking and opening many new doors for other positions, including considering running for the Board of Directors member-at-large position for ONS this past year. Keep your mind open, be willing to listen, and accept new opportunities." Timestamp (TS) 21:03
Jeanene "Gigi" Robison: "When we look at people in our lives and they are in leadership positions, whether that be locally or nationally, I think that they are good resource people for us when we have questions about pursuing that same direction." TS 26:34
Gigi Robison: "Be open minded and think outside of the box. I believe it is crucial to listen to as many people as you can in order to have a diverse perspective." TS 37:12
Hutch Allen: "I think it's harder to step back and say, 'I'm not the expert,' but I am a lifelong learner. I love finding that 'aha!' when I learn how to apply it to my life and into my practice, and I think that's the most important thing of becoming a board member and always saying to our members that I have to step out of myself, keep an open mind, listen, and provide feedback." TS 38:33
Kris Mathey: "You really never know what you are going to gain from the people around you." TS 40:47
Kris Mathey: "It takes only one chance to really get to where you're going. And you may fail along the way, but those are all learning experiences that are going to make you stronger." TS 41:23
Kris Mathey: "My board involvement really fills my bucket and fills my heart and has really given me that extra—on those hard days at work when I just want to scream sometimes, the involvement in this has really made a difference and helps me keep going." TS 45:38
"Genomics is part and parcel of oncology treatment today. Even if a patient's genomics might not affect the current choice of therapy, it may do so in the future. The use of genomics and biomarkers is just an evidence-based expansion and extension of our previous care," ONS member Kristin Daly, MSN, ANP-BC, AOCNP®, nurse practitioner at the Washington University School of Medicine in St. Louis, MO, said in a conversation with Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS. Daly and Weimer discussed oncology nurses' educational needs to bridge knowledge gaps in cancer genomics, identified genomics tools and resources specifically designed for clinical nursing practice, and shared strategies to implement them inn your patient care processes. Daly presented on the topic during the 2022 ONS Bridge™ virtual conference in September 2022. You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: The learner will report an increase in knowledge related to cancer genomics.
Episode Notes
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From Today's Episode
"Precision medicine, genomics, and biomarkers aren't just buzzwords or trendy new terms. They are the tools that enable oncologists to continue to refine and improve what we have always striven for in oncology care—the continual and ongoing search to provide the most appropriate, and crucially, the most effective treatments for our patients. The use of genomics and biomarkers is just an evidence-based expansion and extension of our previous care." Timestamp (TS) 03:39
"Our healthcare colleagues, especially our physician colleagues, are often not aware of our nursing training and curriculum. And therefore, sometimes they're unaware of both our strengths and gaps in our knowledge compared to medical training, especially when we enter a specialized area of nursing like oncology. . . . And that's a gap between our healthcare colleagues' knowledge of what our formal training has been and our formal education has been and the kind of care we're supposed to provide and understanding the science behind that care." TS 10:52
"Genomics is part and parcel of oncology treatment today. It should be a part of a patient's evaluation and record at every point in their cancer journey. Even if a patient's genomics might not affect the current choice of therapy, it may do so in the future. So, it's important, and it's important to have it documented." TS 18:25
"Many new oncology nurses have less time and training, fewer opportunities for in-person education, and fewer experienced nurses to serve as mentors and sources of knowledge. All of this, coupled with that increase pace of change and treatments for a variety of cancers. So, keeping up and staying current is, I know, particularly challenging in these circumstances. And I have to say, I am always so impressed by how oncology nurses come up with solutions, share information, and seek out opportunities to learn in order to take the best care of their patients." TS 20:46
"It's important to make it a priority, to set some time aside, regularly for continuing education, however you do that. . . and to use these types of tools. And if you find websites that you find particularly helpful, bookmark them on your phone or computer so they're easily accessible and to share them with other people." TS 33:05